These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34185710)

  • 1. Lenvatinib halts aortic aneurysm growth by restoring smooth muscle cell contractility.
    Busch A; Pauli J; Winski G; Bleichert S; Chernogubova E; Metschl S; Winter H; Trenner M; Wiegering A; Otto C; Fischer J; Reiser J; Werner J; Roy J; Brostjan C; Knappich C; Eckstein HH; Paloschi V; Maegdefessel L
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34185710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin Prevents Abdominal Aortic Aneurysm via Activation of Vascular Smooth Muscle Cell Transcription Factor EB.
    Lu H; Sun J; Liang W; Chang Z; Rom O; Zhao Y; Zhao G; Xiong W; Wang H; Zhu T; Guo Y; Chang L; Garcia-Barrio MT; Zhang J; Chen YE; Fan Y
    Circulation; 2020 Aug; 142(5):483-498. PubMed ID: 32354235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion.
    Li G; Qin L; Wang L; Li X; Caulk AW; Zhang J; Chen PY; Xin S
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1110-H1119. PubMed ID: 28213405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of aortic smooth muscle cell secretions reveals an association of myosin heavy chain 11 with abdominal aortic aneurysm.
    Yokoyama U; Arakawa N; Ishiwata R; Yasuda S; Minami T; Goda M; Uchida K; Suzuki S; Matsumoto M; Koizumi N; Taguri M; Hirano H; Yoshimura K; Ogino H; Masuda M; Ishikawa Y
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1012-H1018. PubMed ID: 30004237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells.
    Tsai SH; Hsu LA; Tsai HY; Yeh YH; Lu CY; Chen PC; Wang JC; Chiu YL; Lin CY; Hsu YJ
    FASEB J; 2020 Jul; 34(7):9498-9511. PubMed ID: 32463165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting vascular smooth muscle cell dysfunction with xanthine derivative KMUP-3 inhibits abdominal aortic aneurysm in mice.
    Lai CH; Chang CW; Lee FT; Kuo CH; Hsu JH; Liu CP; Wu HL; Yeh JL
    Atherosclerosis; 2020 Mar; 297():16-24. PubMed ID: 32059119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPV5 attenuates abdominal aortic aneurysm in mice by regulating KLF4-dependent phenotype switch of aortic vascular smooth muscle cells.
    Wang S; Tian X; Liu D; Zhang X; Yan C; Han Y
    Arch Biochem Biophys; 2021 Feb; 698():108724. PubMed ID: 33309615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms.
    Sho E; Chu J; Sho M; Fernandes B; Judd D; Ganesan P; Kimura H; Dalman RL
    J Vasc Surg; 2004 Jun; 39(6):1312-21. PubMed ID: 15192574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H19 Induces Abdominal Aortic Aneurysm Development and Progression.
    Li DY; Busch A; Jin H; Chernogubova E; Pelisek J; Karlsson J; Sennblad B; Liu S; Lao S; Hofmann P; Bäcklund A; Eken SM; Roy J; Eriksson P; Dacken B; Ramanujam D; Dueck A; Engelhardt S; Boon RA; Eckstein HH; Spin JM; Tsao PS; Maegdefessel L
    Circulation; 2018 Oct; 138(15):1551-1568. PubMed ID: 29669788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.
    Tarín C; Fernandez-Garcia CE; Burillo E; Pastor-Vargas C; Llamas-Granda P; Castejón B; Ramos-Mozo P; Torres-Fonseca MM; Berger T; Mak TW; Egido J; Blanco-Colio LM; Martín-Ventura JL
    Cardiovasc Res; 2016 Aug; 111(3):262-73. PubMed ID: 27229458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
    Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity.
    Li FF; Shang XK; Du XL; Chen S
    Curr Med Sci; 2018 Feb; 38(1):93-100. PubMed ID: 30074157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression.
    Tedesco MM; Terashima M; Blankenberg FG; Levashova Z; Spin JM; Backer MV; Backer JM; Sho M; Sho E; McConnell MV; Dalman RL
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1452-7. PubMed ID: 19574559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
    Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
    Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
    Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
    PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation.
    Wang Q; Liu Z; Ren J; Morgan S; Assa C; Liu B
    Circ Res; 2015 Feb; 116(4):600-11. PubMed ID: 25563840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype.
    Mukherjee K; Gitlin JM; Loftin CD
    J Cardiovasc Pharmacol; 2012 Dec; 60(6):520-9. PubMed ID: 22967986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression.
    Kamijima T; Isobe M; Suzuki J; Fukui D; Arai M; Urayama H; Nishimaki K; Sekiguchi M; Kawasaki S
    Cardiovasc Pathol; 1999; 8(5):291-5. PubMed ID: 10533961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.
    Metghalchi S; Vandestienne M; Haddad Y; Esposito B; Dairou J; Tedgui A; Mallat Z; Potteaux S; Taleb S
    PLoS One; 2018; 13(3):e0193737. PubMed ID: 29494675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.
    Fernandez-García CE; Tarin C; Roldan-Montero R; Martinez-Lopez D; Torres-Fonseca M; Lindhot JS; Vega de Ceniga M; Egido J; Lopez-Andres N; Blanco-Colio LM; Martín-Ventura JL
    Clin Sci (Lond); 2017 Nov; 131(22):2707-2719. PubMed ID: 28982723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.